Drug Information Association Logo
Corporate Tagline
Employing Recent Advances to Improve Patient Safety and Speed Up the Pipeline

Employ Recent Advances to Improve Patient Safety

Explore the current state of the art as well as how our evolving understanding of underlying mechanisms is leading to new strategies for risk assessment and mitigation.

Learn More
Designed for Success: Utilizing Protocol Quality by Design to Plan Clinical Studies

Successfully Implement Quality by Design

Discuss regulatory expectations for applying Protocol Quality by Design (QbD), the concepts of QbD including protocol design, trial operations, monitoring, and quality improvement, and more.

Learn More
DIA 2014 50th Annual Meeting: Preliminary Program Released

Register by May 9 to Make the Advance Attendee List!

The DIA Annual Meeting is the largest multidisciplinary event that brings together a community of life sciences professionals. Register today!

Learn More
Key Considerations for the Development and Marketing of Biosimiliar Products

Overcome Challenges to Development and Market Entry

Get a hands-on learning experience to understand how a follow-on biologic or candidate biosimilar product is developed, regulated, and registered for global commercialization. Register 3, get the 4th FREE!

Learn More
Latin American Regulatory Conference (LARC) 2014

Register by May 2 to Make the Advance Attendee List

Interact with regulatory agencies, industry, and academia about the current and future regulatory landscape in Latin America. Register today!

Learn More

GO From the Editor's Desk

What Lies AheadWhat Lies Ahead for 2014?

DIA's second annual What Lies Ahead? report, provides expert insight into the year ahead for pharmaceuticals, biotechnology, and the product development of medical devices.

Read report

Breaking News

DIA Making News from 26th Annual EuroMeeting

Pharma 'missing an opportunity with remote monitoring technologies'

Read report

Absence of Good Practices a Flaw in Global Drug Harmonization Activities

Read report

Orphan Drug Talks & Midnight Meetings Under Japan-EMA Collaborations

Read report

EU Pediatric Rules are Top Regulatory Headache for Drug Companies; Variations & Fees Close Behind

Read report

DIA Launches New TIRS Blog

DIA’s journal, Therapeutic Innovation & Regulatory Science, has launched a new blog, titled “Collaborate to Innovate.” The blog aims to further public conversation about global therapeutic advances and regulatory policies by offering expert insight on current trends and fresh perspectives on timely industry news. Read the blog. Don’t forget to follow the blog to stay current on new entries.

The blog is just another facet of TIRS’ multimedia approach to industry news. We also offer monthly podcasts, featuring commentary by industry experts. They are available on the blog. Listen to Podcasts.

Both the blog and our podcasts are complimentary to all site visitors, so please share them with your professional network.


Barbara Lopez-Kunz

Read Global Chief Executive Barbara Lopez Kunz's March Message


DIANew! Content Currents

DIA's Content Currents provides important new global regulatory developments and their impact on pharmaceutical, biotechnology, and medical product development.

Read current issue. 

SCRIP100.comNew! DIA Europe and Director Jytte Lyngvig were spotlighted in SCRIP100.com.

Read their profile "A Forum for Future Leaders."

Global ForumApril 2014 Global Forum Now Online: The US National Institutes of Health estimates that there are approximately 6,000 rare diseases affecting 25 million Americans. EURORDIS, the Voice of Rare Disease Patients in Europe, estimates the number of persons in Europe suffering from a rare disease at over 30 million. This Special Section Orphan Drugs in the 21st Century explores different strategies and pathways to meet the needs of patients around the world with rare diseases, including an interview with the Director of the FDA Office of Orphan Product Development. Also Featured: Our interview with DIA 2014 50th Annual Meeting Keynote Speaker Jamie Heywood, and previews of our 6th Latin American Regulatory Conference: LARC 2014 and our 8th Annual Conference in Japan for Asian New Drug Development.

Read the April issue.

TIRSGuest Commentary: Therapeutic Innovation & Regulatory Science - March 2014

Steven P Spielberg MD, PhD Discusses the Evolution of Therapeutic Interventions that have Stemmed from the AIDS Epidemic


Read full commentary.

Read more TIRS articles.

NEW! Read our blog.

GO DIA 2014 50th Annual Meeting

DIA 2014 50th Annual Meeting: Celebrate the Past - Invent the Future

June 15-19 | San Diego, CA

This year marks the 50th Anniversary of the DIA Annual Meeting, the largest multidisciplinary event that brings together a global network of life sciences professionals to foster innovation that will lead to the development of safe and effective medical products and therapies to patients. With this year’s theme, Celebrate the Past - Invent the Future, we will be doing just that and DIA invites YOU to join us in San Diego. Register Early to Save!

The DIA Annual Meeting is the best opportunity to meet with people from around the world, share your views and knowledge, network, and build new relationships.

Schedule At-A-Glance | Overview | Register Now | Justification Letter

View the Continuing Education credits that are available.

Search more than 260 educational offerings over 21 tracks on today’s hottest topics!

Search by country/region on today’s hottest topics too!

HeywoodThis year’s Keynote Speaker!

Jamie Heywood
Co-Founder and Chairman, PatientsLikeMe
Founding Director, ALS Therapy Development Institute

Monday, June 16 | 2:30PM PT

GO Meetings & Training

Educational Opportunities

DIA’s comprehensive educational portfolio reflects and advances innovation in the pharmaceutical, biotechnology, medical device, and related fields and facilitates open dialogue among key professionals from industry, government, academia, and patient organizations. Professional development options include:

Conferences & Meetings | In-Person Training | In-company Training |Online Learning | Certificate Programs

Pictures from the 2013 US Conference on Rare Diseases and Orphan Products: New Era in Healthcare

Conference held October 7-9, 2013 at the Bethesda North Marriott Hotel and Conference Center in North Bethesda, MD. This conference was sponsored by NORD and DIA (the Drug Information Association). 

Upcoming educational opportunities in your region:

GO Member Benefits

MembershipNew! Free access to one of DIA's archived webinars featuring up-to-the-minute information about the latest developments in the medical product industry

Just added! The Impact of Drug Shortages on the Pharmaceutical Industry

More than 18,000 members worldwide look to DIA as the only global, neutral, nonprofit, multidisciplinary association to address the challenges you face every day. Take advantage of all the benefits of membership, including:

DIA ConneXDIA ConneX is a trusted, interactive, web-based network that links DIA’s 18,000-member global community. DIA members use ConneX to collaborate, communicate, network, and exchange information. Through ConneX, DIA members:

  • Share documents
  • Engage in online discussions
  • Post community event information
  • Make announcements and post news
  • Join Communities (formerly SIACs)


GO Exhibiting & Advertising

Showcase your company's products or services to key decision-makers from across the pharmaceutical, biotechnology, medical device, and related fields.

Contract Service OrganizationsContract Service Organization (CSO) Directory 

Reserve your spot in our exclusive print and online partner directory featuring full-page descriptions and contact information for yours and other clinical trial and medical product development service companies around the world.

View partner listings.


Exhibiting Opportunities

Join DIA and an anticipated 450+ companies with a booth at the DIA 2014 50th Annual Meeting! 

Upcoming exhibiting opportunities in your region:

Drug Information Journal

Advertise your company's products and services to professionals from the pharmaceutical, biotechnology, medical device, and related sectors.

Global Forum

Place your advertising message in front of more than 18,000 professionals involved in every aspect of medical product discovery, development, and delivery.


GO Communities Showcase


New Era for Communities

DIA is a global member association that provides knowledge resources across the full spectrum of medical product development. In the last few years the organization has expanded that global reach and will continue to grow to meet the need for health care knowledge exchange around the world.

As DIA’s reach expands globally we believe a name change is necessary. Our global volunteers came to consensus on "Community" to replace "SIACs." This change will enhance the visibility of the groups and make it much easier to recognize their purpose.

Each Community is led by a chairperson who is responsible for the overall activities of the Community. View complete list of Community chairpersons.

GO Student Initiatives

DIA offers students many opportunities to get involved and contribute in a collegial, inclusive, collaborative, positive, respectful, and professional environment in support of DIA’s mission. available student opportunities include:

  • Student Volunteer Program
  • Young Professionals Fellowship Program
  • Student Fellowship Program
  • Complimentary EuroMeeting registration
  • Student Poster Session (North America, Europe, China Annual Meetings)
  • Discount registration (North America and Europe Annual Meetings)
  • Group Discounts for DIA Student Chapter members
  • Student Membership
  • Student Engagement at DIA Annual Meeting
  • Student Chapters

Featured Story

Breaking NewsMedical Students Remain Unfazed by Professors Industry Relationships

Read article.


Featured Video

Medical Genetics Residency Programs: Medical Genetics is Transforming Medicine

GO Patient Initiatives

Through DIA’s worldwide conferences and programs, patient representatives have opportunities to develop, strengthen, and support collaborations with policymakers, health professionals, industry representatives, and academia while promoting dialogue and sharing best practices.

Help Reduce Your Risk of Birth Defects

Watch this video from the National Birth Defects Prevention Network (NBDPN), a volunteer-based organization that addresses the issues of birth defects surveillance, research and prevention under one umbrella by maintaining a national network of state and population-based birth defects programs.